CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 400 enrolled
Drug / intervention
Moderate Volume +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01435005
NCT01435005N/ACompleted
CompareCT.gov

Breast Cancer and Exercise Trial in Alberta: The BETA Trial

AHS Cancer Control Alberta·interventional·Posted Sep 15, 2011·Updated Jan 30, 2018

In Brief

A clinical study evaluating Moderate Volume and High Volume for Breast Neoplasms. Completed, enrolled 400 participants across 2 sites.

Detailed Summary

The Breast Cancer and Exercise Trial (BETA Trial) is a randomized controlled trial aimed at understanding what dose (or volume) of exercise will best reduce the risk for breast cancer, particularly among women who are between the ages of 50-74. The primary aim is to compare the effects of a high versus moderate volume exercise intervention on specific biological intermediate endpoints for breast cancer in a group of previously inactive postmenopausal women

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Neoplasms
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 15, 2011
Enrollment StartMar 1, 2010
Primary CompletionApr 1, 2013
Study CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 14.8 years ago

Interventions

Moderate Volumeother

Moderate volume (150 minutes per week) aerobic exercise

High Volumeother

Participate in one-year high volume (300 minutes per week)aerobic exercise.